Stay updated with breaking news from Zero Life Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Toronto, Ontario--(Newsfile Corp. - March 30, 2023) - StageZero Life Sciences (TSX: SZLS) ("StageZero" or the "Company") today announced that it will release its fourth quarter and year end 2022 operational
StageZero Life Sciences Ltd. (OTCMKTS:SZLSF – Get Rating) was the target of a significant growth in short interest in March. As of March 15th, there was short interest totalling 30,000 shares, a growth of 934.5% from the February 28th total of 2,900 shares. Based on an average trading volume of 9,100 shares, the short-interest ratio […]
StageZero Life Sciences Ltd. (OTCMKTS:SZLSF – Get Rating) was the recipient of a significant growth in short interest during the month of March. As of March 15th, there was short interest totalling 30,000 shares, a growth of 934.5% from the February 28th total of 2,900 shares. Based on an average trading volume of 9,100 shares, […]
StageZero Life Sciences (OTCMKTS:GNWSF – Get Rating) is one of 40 publicly-traded companies in the “Diagnostic Substances” industry, but how does it weigh in compared to its competitors? We will compare StageZero Life Sciences to related companies based on the strength of its dividends, profitability, analyst recommendations, risk, earnings, institutional ownership and valuation. Valuation & […]
StageZero Life Sciences (OTCMKTS:GNWSF – Get Rating) is one of 40 public companies in the “Diagnostic Substances” industry, but how does it weigh in compared to its competitors? We will compare StageZero Life Sciences to similar businesses based on the strength of its dividends, earnings, valuation, analyst recommendations, profitability, institutional ownership and risk. Valuation and […]